Dova Pharmaceuticals (DOVA) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts DOVA Hot Sheet
Join SI Premium – FREE
Dova Pharmaceuticals (NASDAQ: DOVA) reported Q4 EPS of ($0.36), in-line with the analyst estimate of ($0.36).
For earnings history and earnings-related data on Dova Pharmaceuticals (DOVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Movano (MOVE) Misses Q2 EPS by 195c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
